The global probiotic market was estimated at $ 54.77 billion in 2020 by Grandview Research and is projected to grow at an average annual growth rate (CAGR) of 7.2% from 2021 to 2028.
The market is being driven by the growing consumer demand for preventive health care coupled with the development of efficient probiotic strains. Probiotics, when consumed in sufficient quantities, have beneficial effects on the body. They play a huge role in health care as they prevent disease from occurring by strengthening the immune system. The increasing awareness of preventive health care will further stimulate market growth.
Trends
- The development and introduction of new probiotic strains with new functions and applications contribute significantly to market growth.
- Research into extended shelf life, increased resistance and targeted effectiveness of probiotics is developing at a constant level.
- New product categories such as functional food and synbiotic drinks as well as innovative dosage forms such as chewing capsules, chewing gum and lozenges are establishing probiotics as lifestyle products among dietary supplements.
Demand
- The increasing importance of health and fitness, especially during the COVID-19 pandemic, is increasing the demand for probiotic food supplements.
- Unbalanced diet, unhealthy lifestyle, stress in everyday life, hormonal imbalance, but also the excessive use of antibiotics are reasons for the growing interest in probiotics to improve and maintain health.
- Probiotic food supplements with a wide range of applications are a simple means of calming the intestinal flora and preventing diseases, which is why they are mainly used by health-conscious people.
Challenges
- The probiotic market is highly fragmented. A few key players operate around the world and are present in the most important markets. The largest players are pursuing a growth strategy by taking over regional companies.
- New products, improved product quality and technological innovations are intensifying competition in the probiotics market.
- With growing medical evidence, probiotics that have been shown to be suitable as dietetic foods for special medical purposes could increasingly be approved as novel foods or novel drugs, which will further promote the acceptance and use of probiotic preparations for medical purposes.
Advanced Microbiotcs AG covers the entire value chain from research & development, production and marketing.
Our success factors are:
- A consortium of unique, highly potent and patented microbiotic cultures with the highest concentration of living organisms and clinically proven medicinal properties.
- An international network of medical experts for the development of microbiotic therapies and for the implementation and evaluation of clinical studies
- A broad and differentiated portfolio of powerful, probiotic products, applications and therapies for medical professionals and for self-medication.
- A highly qualified team of microbiologists with scientifically proven technologies for the production of best-in-class probiotics.
With the support of our partner Bellerive Capital AG, Zurich, we offer selected investors the opportunity to participate in our growth strategy and benefit from the high transaction and acquisition potential in the probiotics market.